Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis
(Q46140186)
scientific article published in February 2009
scientific article published in February 2009
Language: